1,873 reports of this reaction
6.5% of all CENEGERMIN BKBJ reports
#2 most reported adverse reaction
EYE IRRITATION is the #2 most commonly reported adverse reaction for CENEGERMIN BKBJ, manufactured by Domp farmaceutici S.p.A.. There are 1,873 FDA adverse event reports linking CENEGERMIN BKBJ to EYE IRRITATION. This represents approximately 6.5% of all 28,659 adverse event reports for this drug.
Patients taking CENEGERMIN BKBJ who experience eye irritation should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
EYE IRRITATION is moderately reported among CENEGERMIN BKBJ users, representing a notable but not dominant share of adverse events.
In addition to eye irritation, the following adverse reactions have been reported for CENEGERMIN BKBJ:
The following drugs have also been linked to eye irritation in FDA adverse event reports:
EYE IRRITATION has been reported as an adverse event in 1,873 FDA reports for CENEGERMIN BKBJ. This does not prove causation, but indicates an association observed in post-market surveillance data.
EYE IRRITATION accounts for approximately 6.5% of all adverse event reports for CENEGERMIN BKBJ, making it one of the most commonly reported side effect.
If you experience eye irritation while taking CENEGERMIN BKBJ, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.